Alberta will cover pricey drug believed to extend and enhance lives of ALS patients

Albertans living with ALS, commonly referred to as Lou Gehrig’s Disease, have a new treatment option that can improve their quality of life and help them live longer, and the Alberta government will cover the estimated $18,500 a month per patient.